Digital therapeutics represents a new approach to supporting and improving
patient journey.
Digital
Therapeutics (DTx)
What are Digital Therapeutics?
Digital Therapeutics, by definition, provide evidence-based therapeutic interventions that are driven by high-quality software programs to prevent, manage or treat a medical condition or disease.
They are used independently or in conjunction with drugs, medical devices or other therapies to optimize patient care and health outcomes.
What are Digital Therapeutics?
Digital Therapeutics, by definition, provide evidence-based therapeutic interventions that are driven by high-quality software programs to prevent, manage or treat a medical condition or disease.
They are used independently or in conjunction with drugs, medical devices or other therapies to optimize patient care and health outcomes.
Digital therapeutics: a personalized treatment
In addition to conventional medicines, KLAVA Innovation develops digital therapeutic solutions that can offer new alternatives to patients and healthcare professionals currently facing unmet medical needs in these areas.
Digital therapeutics:
a personalized treatment
In addition to conventional medicines, KLAVA Innovation develops digital therapeutic solutions that can offer new alternatives to patients and healthcare professionals currently facing unmet medical needs in these areas.
Transforming diagnostic assessment and developing new therapies
Therapeutic App
Technological tools such as mobile phones and connected objects hold the promise of profound changes both in terms of transforming diagnostic assessment and developing new therapies.
These tools collect data from the patient on self-assessment questionnaires and active tests and collect data to monitor, with the patient’s consent, in real time, the evolution of their disease.
Transforming diagnostic assessment and developing new therapies
Therapeutic App
Technological tools such as mobile phones and connected objects hold the promise of profound changes both in terms of transforming diagnostic assessment and developing new therapies.
These tools collect data from the patient on self-assessment questionnaires and active tests and collect data to monitor, with the patient’s consent, in real time, the evolution of their disease.
